dalteparin has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schinzel, H | 1 |
| Berghoff, K | 1 |
| Beuermann, I | 1 |
| Sauer, O | 1 |
| von Mach, MA | 1 |
| Weilemann, LS | 1 |
1 trial available for dalteparin and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Anticoagulation with low-molecular-weight heparin (dalteparin) in plasmapheresis therapy: initial experience.
Topics: Adult; Anticoagulants; Dalteparin; Guillain-Barre Syndrome; Humans; Monitoring, Physiologic; Myasthe | 2006 |